Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $18.6M | -- | -- | -$0.02 | -- |
| 02/24/2026 | Q4 | $18.5M | -- | -- | -$0.03 | -- |
| 11/04/2025 | Q3 | $18M | $19.6M | -$0.09 | -$0.02 | -$0.07 |
| 08/11/2025 | Q2 | $39.8M | $21.8M | -$0.09 | -$0.04 | -$0.05 |
| 05/07/2025 | Q1 | $40.1M | $40.8M | -$0.07 | -$0.04 | -$0.03 |
| 02/26/2025 | Q4 | $43M | $46.7M | -$0.09 | -$0.03 | -$0.06 |
| 10/30/2024 | Q3 | $41M | $22.1M | -$0.07 | -$0.08 | $0.00 |
| 07/31/2024 | Q2 | $48.2M | $22.5M | -$0.12 | -$0.07 | -$0.05 |
| 05/08/2024 | Q1 | $46M | $45.5M | -$0.27 | -$0.10 | -$0.16 |
| 02/28/2024 | Q4 | $24.9M | $28.2M | -$0.25 | -$0.13 | -$0.12 |
| 11/07/2023 | Q3 | -- | $25.4M | -$0.27 | -- | -- |
| 08/08/2023 | Q2 | -- | $27.7M | -$0.22 | -- | -- |
| 05/09/2023 | Q1 | -- | $25.1M | -$0.21 | -- | -- |
| 02/14/2023 | Q4 | -- | $27M | -$0.26 | -- | -- |
| 11/08/2022 | Q3 | -- | $25.6M | -$0.37 | -- | -- |
| 08/08/2022 | Q2 | -- | $18.8M | -$0.82 | -- | -- |
| 05/05/2022 | Q1 | -- | $26.5M | -$0.99 | -- | -- |
| 02/17/2022 | Q4 | -- | $38.3M | -$0.12 | -- | -- |
| 09/30/2021 | Q3 | -- | $28.5M | -$0.18 | -- | -- |
| 06/30/2021 | Q2 | -- | $31M | -$0.23 | -- | -- |
| 03/31/2021 | Q1 | -- | $32.8M | -$0.25 | -- | -- |
| 12/31/2020 | Q4 | -- | $44.6M | -$0.24 | -- | -- |
| 09/30/2020 | Q3 | -- | $39.9M | -$0.08 | -- | -- |
| 06/30/2020 | Q2 | -- | $26.1M | -$0.18 | -- | -- |
| 03/31/2020 | Q1 | -- | $27.6M | -$0.23 | -- | -- |
| 12/31/2019 | Q4 | -- | $32.4M | -$0.18 | -- | -- |
| 09/30/2019 | Q3 | -- | $26.5M | -$0.19 | -- | -- |
| 06/30/2019 | Q2 | -- | $28.2M | -$0.20 | -- | -- |
| 03/31/2019 | Q1 | -- | $30.1M | -$0.44 | -- | -- |
| 12/31/2018 | Q4 | -- | $32.3M | -$0.36 | -- | -- |
| 09/30/2018 | Q3 | -- | $29M | -$0.38 | -- | -- |
| 06/30/2018 | Q2 | -- | $26.4M | -$0.42 | -- | -- |
| 03/31/2018 | Q1 | -- | $25.2M | -$0.34 | -- | -- |
| 12/31/2017 | Q4 | -- | $27.7M | -$0.27 | -- | -- |
| 09/30/2017 | Q3 | -- | $24.7M | -$0.46 | -- | -- |
| 06/30/2017 | Q2 | -- | $23.9M | -$0.58 | -- | -- |
| 03/31/2017 | Q1 | -- | $25.5M | -$0.59 | -- | -- |
| 12/31/2016 | Q4 | -- | $25.1M | -$0.61 | -- | -- |
| 09/30/2016 | Q3 | -- | $22.2M | -$0.68 | -- | -- |
| 06/30/2016 | Q2 | -- | $28.2M | -$0.64 | -- | -- |
| 03/31/2016 | Q1 | -- | $29M | -$0.69 | -- | -- |
Standard BioTools, Inc. reported $19.6M worth of top line sales in its most recent quarter.
Standard BioTools, Inc. announced earnings per share of -$0.09 which represents a miss of analyst forecast a -$0.02 per share.
Standard BioTools, Inc. reported $9.5M that represents $0.02 per share over the last quarter.
Standard BioTools, Inc.'s earnings are forecast to decrease from -$0.52 per share to -$0.11 per share next year representing a decrease of -78.98%.
Standard BioTools, Inc.'s next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.